17.08.2023
The MHRA has appointed two new UK Approved Bodies for medical devices, namely the UK affiliates of EU Notified Bodies TÜV Rheinland and TÜV SÜD. The former has also been designated as an Approved Body for in vitro diagnostic medical devices (IVDs). This means there are now six UK Approved Bodies capable of conducting
Key points to take away from recent UK cases on patent licence agreements
16.08.2023
Cases concerning patent licences in the English courts are a bit like London buses: you don’t see any for a very long time and then three turn up at once. In this note, we summarise the key take away points that
15.08.2023
The Department of Health and Social Care (DHSC) recently announced a consultation for a review of the statutory scheme for branded medicines (the ‘Statutory Scheme’). The proposed amendments (1) increase the allowed growth rate under the Scheme; (2) add new exemptions, including one for new active substances; and (3) introduce a lifecycle adjustment mechanism
14.08.2023
On 25 July 2023, Jamie Drucker and Faye Harrison, from our renowned data protection and privacy team, hosted a LexisNexis webinar on the future of cookie pop-ups.
The webinar looks at the legal and regulatory landscape relating to cookies, other tracking technologies and the wider AdTech environment. Jamie and Faye discuss the
14.08.2023
On 1 August 2023, the UK Department for Business and Trade (DBT) announced that CE marks would continue to be recognised in Great Britain (GB) indefinitely for virtually all goods, including toys, fireworks and radio equipment.
In effect, the UK Government has largely abandoned its version of the CE Mark, the UKCA Mark.
Before
09.08.2023
EU and UK competition law expert, Sophie Lawrance, has been quoted in The Times’ article, ‘Advanz Pharma and former owners face £176m bill after 6,000% price rise for NHS’.
The piece summarises Advanz Pharma’s use of a loophole in pricing rules to overcharge for its medicine ALAMY. The CMA imposed a fine of
How the National Security and Investment Act 2021 could impede transactions involving companies ‘active’ in Artificial Intelligence
03.08.2023
The emergence of Artificial Intelligence as the topic at the forefront of the technology sector in the past couple of years has prompted a trend amongst governments and associated bodies to warn of the dangers AI poses
The comments follow the Competition Appeals Tribunal agreeing to a conditional adjournment to Microsoft and Activision’s appeal against the prohibition decision by the Competition and Markets Authority.
02.08.2023
EU and UK competition law experts, Stephen Smith and Victoria Yuan, have been quoted in CTFN’s article on 28 July 2023, ‘ATVI/MSFT: Parties likely to face
31.07.2023
Bristows was delighted to host 12 fantastic year 12 students for its second annual Joe Sako Summer Workshop. Between 10-13 July, these students visited our offices to learn more about a career in law and a variety of legal practice areas, to develop their soft skills in a series of presentations, practical sessions and
25.07.2023
First published in Kluwer Patent Blog, July 2023.
On 17 July 2023, the English Court of Appeal handed down its decision in a dispute between J.C. Bamford (JCB) and Manitou about the confidentiality of information disclosed in the course of litigation between JCB and Manitou relating to the validity and infringement of certain of